INSIGHTS ON CLINICAL TRIAL PARTNERING

• Executing A Complex Global Breast Cancer Trial In A Rapidly Evolving Treatment Landscape

  See how rapid site activation, strong oncology site relationships, and adaptive protocol management kept a complex global cancer trial on track amid evolving standards of care.

• Enabling You And Your Sites To Trial Wisely

  Clinical trial sites are asked to do more with less, and these examples show how a connected approach to site enablement drives measurable efficiencies and strengthens relationships.

• Consolidating Access Into A Single Platform: A Site CEO's Perspective

  By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.

• Cell & Gene Unscripted: Project Management

  What does operational excellence look like in early-phase trials? Melissa de LaFe & Chris Learn go behind the scenes on the latest Cell & Gene Unscripted.

• Dedicated Community Oncology Sites

  7/29/2026

  Rapid activation, strong referral partnerships, diverse patient access, and specialized immunotherapy infrastructure are reshaping oncology research.

• Research Study Rockstar: Full -Service Trial Advertising Support

  7/29/2026

  Learn how clinical research organizations are combining digital marketing, community engagement, analytics, and technology integrations to improve patient recruitment

• Turning Patient Advocacy Into Meaningful Trial Engagement

  8/18/2026

  See how structured PAO engagement can inform protocol design, reduce participation barriers, and strengthen recruitment and retention.

• Delivering Complex Oncology Trials At Scale

  5/19/2026

  Parexel delivered two complex, global Phase III prostate cancer trials by aligning site selection, logistics, imaging workflows, and RAM regulatory expertise—achieving faster enrollment and on‑time execution.

• Effective Study Design And Execution Of Renal And Hepatic Impairment Trials

  5/1/2026

  Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired populations.